Clinical Trials Logo

Mild Cognitive Impairment clinical trials

View clinical trials related to Mild Cognitive Impairment.

Filter by:

NCT ID: NCT05438147 Completed - Cancer Clinical Trials

Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms

Start date: May 13, 2022
Phase: N/A
Study type: Interventional

CT-100 is a platform that provides an interactive, software based therapeutic component that may be used as part of a multimodal treatment in supplementary or standalone prescription or nonprescription software-based digital therapeutics (PDT/DTx), being developed by Click Therapeutics, Inc.

NCT ID: NCT05408689 Completed - Clinical trials for Mild Cognitive Impairment

Effects of Transcutaneous Electrical Nerve Stimulation (TENS) to Improve the Cognitive Functions in Older Adults

Start date: May 23, 2022
Phase: N/A
Study type: Interventional

Recent evidence has shown that transcutaneous electrical nerve stimulation (TENS) was effective in improving the cognitive function in healthy adult and people with dementia. However, lacking of evidence investigated the effect of TENS in improving the cognitive function and reversing the occurrence of dementia during the period of mild cognitive impairment (MCI), which is the crucial period to prevent the significant loss of cognition function. Therefore, the main objective of this study is to investigate the optimal TENS treatment protocol in improving the cognitive function in older adults with MCI.

NCT ID: NCT05383053 Completed - Alzheimer Disease Clinical Trials

Evaluating the Efficacy of Artificial Intelligence-based Computer Aided Diagnosis Software That Assists in Determining Whether or Not to Conduct Amyloid PET for the Diagnosis of Alzheimer's Disease by Predicting Amyloid PET Positivity in Mild Cognitive Impairment Patients

Start date: July 22, 2022
Phase:
Study type: Observational

- Purpose of clinical trial; This clinical trial is designed to evaluate the effectiveness of 'NeuroAI' prediction accuracy compared to the amyloid PET test results by retrospectively collecting medical data of patients with mild cognitive impairment to evaluate the effectiveness of artificial intelligence-based brain image detection and diagnosis assistance software 'NeuroAI'. - Participants; Patient with mild cognitive impairment

NCT ID: NCT05380180 Completed - Aging Clinical Trials

Enhancing Quality of Life for Older Adults With and Without Mild Cognitive Impairment (MCI) Through Social Engagement Over Video Technology

Start date: April 15, 2022
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to rigorously assess the efficacy of an 8-week social engagement OneClick intervention. A total of 120 older adults with and without mild cognitive impairment (60 per group) will be randomized after a baseline assessment to the social engagement OneClick intervention group or the waitlist control group. Participants assigned to the intervention group will receive the social engagement OneClick intervention for 8 weeks, and will complete a mid-assessment at week 4, and a post-assessment at week 8. Participants assigned to the waitlist control group will receive no intervention for the first 8 weeks and will complete assessments at week 4 and week 8. Subsequently, as an extension to this study, participants assigned to the waitlist control group will have an opportunity to participate in 8 weeks of social engagement OneClick intervention, with intervention effects assessed at week 4 and week 8.

NCT ID: NCT05336942 Completed - Clinical trials for Mild Cognitive Impairment

Correlation Between Prognosis of Mild Cognitive Impairment and Hearing Function in Community Elderly

Start date: November 1, 2020
Phase:
Study type: Observational

Cognitive dysfunction is a high incidence disease in the elderly. To date, there is no effective treatment. At the same time, early cognitive impairment is easy to be ignored, delayed intervention. Most patients develop moderate or severe dementia with hearing loss before treatment. At present, there are few studies on the correlation between mild cognitive impairment and hearing function. The investigators evaluated CDR, MMSE, MoCa, and hearing tests at baseline, 6 months later, and 12 months later in a multicenter, randomized cohort study of adults aged 55-65 years. To investigate the correlation between mild cognitive impairment and hearing impairment and its possible predictors. The investigators hope to provide more evidence-based evidence for early identification of mild cognitive impairment.

NCT ID: NCT05318703 Completed - Clinical trials for Mild Cognitive Impairment

Virtual Exercise For Older Adults With Mild Cognitive Impairment

Start date: January 20, 2021
Phase: N/A
Study type: Interventional

This project is designed to develop and evaluate an Internet-based exercise intervention (tai ji quan Moving to Improve Brain Health) using real-time videoconferencing for older adults with mild cognitive impairment (MCI).

NCT ID: NCT05296239 Completed - Quality of Life Clinical Trials

SimpleC Wellness Platform With Social Robot Interaction

Start date: February 3, 2022
Phase: N/A
Study type: Interventional

This implementation study will be conducted to test a Socially-Assistive Robot (SAR) system for residents in an Assisted Living environment. The goal of the SAR system is to enhance social engagement and connectedness. The system engages residents via robot-facilitated activities such as trivia and reminder and is integrated with the SimpleC Wellness Platform.

NCT ID: NCT05275153 Completed - Clinical trials for Mild Cognitive Impairment

Effectiveness of a Home-Based Cognitive Rehabilitation Program in Patients With MCI

Start date: April 22, 2020
Phase: N/A
Study type: Interventional

In this study, a more specific and systematic Home-Based Cognitive Rehabilitation Program Driven by a Tablet Application is developed and the purpose of the program is to check whether cognitive function is improved when the program is applied to patients with MCI.

NCT ID: NCT05253365 Completed - Clinical trials for Mild Cognitive Impairment

French Memory Support System: A Pilot Study

Start date: March 3, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to develop a linguistically and culturally appropriate adaptation of the Memory Support System (MSS), an evidence-based intervention to train persons with mild cognitive impairment (MCI) to complete personal goals and instrumental activities of daily living independently. The study will involve development of the associated manual, training and patient forms, and outcome measures, and pilot testing of the intervention in a group of French-speaking individuals with MCI and their care partners

NCT ID: NCT05229978 Completed - Clinical trials for Mild Cognitive Impairment

Engagement 2.0 Forms of Consent for Data (re-)Use

ENGAGE
Start date: August 17, 2022
Phase:
Study type: Observational

The objective of this qualitative study is to create a better understanding of patients' mental model of health data engagement interfaces and tools (such as Dynamic Consent). The researchers will focus especially on those people who - plausibly - require adjusted communication particularities and interaction modalities due to a cognitive impairment stemming from a neurodegenerative disease. Taking into account the specific characteristics of patients with dementia, the goal of this study is to investigate how to communicate according to patients' personal skills and capabilities and identify both the proper support mechanisms for engagement 2.0 consent as well as feedback mechanisms (return of research results). Through a focus group & interview setup, this study will discern design requirements and propose design recommendations for the (future) development of health data engagement interfaces.